| Product Code: ETC12125153 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Fiji continued to see a high concentration of imports of erlotinib hydrochloride tablets, with top exporting countries including Australia, New Zealand, India, Bangladesh, and the USA. Despite a slight decrease in growth rate from 2023 to 2024, the compound annual growth rate (CAGR) over the period of 2020-2024 remained strong at 6.89%. The high Herfindahl-Hirschman Index (HHI) in 2024 indicates a market still dominated by a few key players. Fiji`s reliance on these top exporting countries for erlotinib hydrochloride tablets underscores the importance of maintaining strong trade relationships to ensure a stable supply of this vital medication.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Fiji Exeter Erlotinib Hydrochloride Tablet Market Overview |
3.1 Fiji Country Macro Economic Indicators |
3.2 Fiji Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, 2021 & 2031F |
3.3 Fiji Exeter Erlotinib Hydrochloride Tablet Market - Industry Life Cycle |
3.4 Fiji Exeter Erlotinib Hydrochloride Tablet Market - Porter's Five Forces |
3.5 Fiji Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Fiji Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.7 Fiji Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume Share, By Therapeutic Class, 2021 & 2031F |
3.8 Fiji Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Fiji Exeter Erlotinib Hydrochloride Tablet Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Fiji Exeter Erlotinib Hydrochloride Tablet Market Trends |
6 Fiji Exeter Erlotinib Hydrochloride Tablet Market, By Types |
6.1 Fiji Exeter Erlotinib Hydrochloride Tablet Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Fiji Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Fiji Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Erlotinib Tablets, 2021 - 2031F |
6.1.4 Fiji Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Erlotinib 100mg Tablets, 2021 - 2031F |
6.1.5 Fiji Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Erlotinib 150mg Tablets, 2021 - 2031F |
6.1.6 Fiji Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Erlotinib 25mg Tablets, 2021 - 2031F |
6.2 Fiji Exeter Erlotinib Hydrochloride Tablet Market, By Dosage Form |
6.2.1 Overview and Analysis |
6.2.2 Fiji Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Oral Tablets, 2021 - 2031F |
6.2.3 Fiji Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By 100mg Tablets, 2021 - 2031F |
6.2.4 Fiji Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By 150mg Tablets, 2021 - 2031F |
6.2.5 Fiji Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By 25mg Tablets, 2021 - 2031F |
6.3 Fiji Exeter Erlotinib Hydrochloride Tablet Market, By Therapeutic Class |
6.3.1 Overview and Analysis |
6.3.2 Fiji Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By EGFR Inhibitors, 2021 - 2031F |
6.3.3 Fiji Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Chemotherapy Drugs, 2021 - 2031F |
6.3.4 Fiji Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Anticancer Medications, 2021 - 2031F |
6.3.5 Fiji Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Chemotherapy Alternatives, 2021 - 2031F |
6.4 Fiji Exeter Erlotinib Hydrochloride Tablet Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Fiji Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Cancer Patients, 2021 - 2031F |
6.4.3 Fiji Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Non-small Cell Lung Cancer, 2021 - 2031F |
6.4.4 Fiji Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Pancreatic Cancer Patients, 2021 - 2031F |
6.4.5 Fiji Exeter Erlotinib Hydrochloride Tablet Market Revenues & Volume, By Patients with Limited Treatment Options, 2021 - 2031F |
7 Fiji Exeter Erlotinib Hydrochloride Tablet Market Import-Export Trade Statistics |
7.1 Fiji Exeter Erlotinib Hydrochloride Tablet Market Export to Major Countries |
7.2 Fiji Exeter Erlotinib Hydrochloride Tablet Market Imports from Major Countries |
8 Fiji Exeter Erlotinib Hydrochloride Tablet Market Key Performance Indicators |
9 Fiji Exeter Erlotinib Hydrochloride Tablet Market - Opportunity Assessment |
9.1 Fiji Exeter Erlotinib Hydrochloride Tablet Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Fiji Exeter Erlotinib Hydrochloride Tablet Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.3 Fiji Exeter Erlotinib Hydrochloride Tablet Market Opportunity Assessment, By Therapeutic Class, 2021 & 2031F |
9.4 Fiji Exeter Erlotinib Hydrochloride Tablet Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Fiji Exeter Erlotinib Hydrochloride Tablet Market - Competitive Landscape |
10.1 Fiji Exeter Erlotinib Hydrochloride Tablet Market Revenue Share, By Companies, 2024 |
10.2 Fiji Exeter Erlotinib Hydrochloride Tablet Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here